Assessing the risks of adverse endocrine-mediated effects: Where to from here?

Regulatory Toxicology and Pharmacology

Volumn 26, Issue 1 I, 1997, Pages 80-93

  Ashby, J ^a   Odum, J ^a   Tinwell, H ^a   Lefevre, P A ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL AGENT; CONTRACEPTIVE AGENT; COUMESTROL; DIETHYLSTILBESTROL; ENVIRONMENTAL CHEMICAL; ESTRADIOL BENZOATE; ESTROGEN; ETHINYLESTRADIOL; METHOXYCHLOR; PESTICIDE; PHTHALIC ACID; PHYTOESTROGEN;

CONFERENCE PAPER; ENDOCRINE DISEASE; ESTROGEN ACTIVITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0030755090     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1006/rtph.1997.1124     Document Type: Conference Paper

References (32)

1. Ames, B. N., and Gold, L. S. (1990). Too many rodent carcinogens. Science 249, 970-971.
2. Arnold, S. F., Klotz, D. M., Collins, B. M., Vonier, P. M., Guillette, L. J., Jr., and McLachlan, J. A. (1996). Synergistic activation of estrogen receptor with combinations of environmental chemicals. Science 272, 1489-1492.
3. Ashby, J. (1996). Mad cows, bats and baby milk. Nature 382, 109.
4. Ashby, J. (1997). A hierarchical approach to the evaluation of chemicals for estrogenic and other endocrine-disrupting properties. Environ. Toxicol. Pharmacol. 3, 87-90.
5. Ashby, J., Houthoff, E., Kennedy, S. J., Stevens, J., Bars, R., Jekat, F. W., Campbell, P., Van Miller, J., Carpanini, F. M., and Randall, G. (1997a). The challenge posed by endocrine disrupting chemicals. Environ. Health Perspect. 105, 164-169.
6. Ashby, J., Lefevre, P. A., Odum, J., Harris, C. A., Routledge, E. J., and Sumpter, J. P. (1997b). Synergism between synthetic oestrogens? Nature 385, 494.
7. Ashby, J., Odum, J., and Foster, J. R. (1997c). Activity of raloxifene in immature and ovariectomized rat uterotrophic assays. Reg. Toxicol. Pharmacol. 25, 226-231.
8. Bliley, R. (1996). Food Quality Protection Act of 1996. 104th Congress, 2nd Session, Report 104-669, Part 2, pp. 1-89.
9. Colborn, T., vom Saal, F. S., and Soto, A. M. (1993). Developmental effect of endocrine disrupting chemicals in wildlife and humans. Environ. Health Perspect. 101, 378-385.
10. Colborn, T., and Clement, C. (Eds.) (1992). Chemically-Induced Alterations in Sexual and Functional Development. Princeton Scientific.
11. Colerangle, J. B., and Roy, D. (1996). Exposure of environmental estrogenic compound nonylphenol to noble rats alters cell-cycle kinetics in the mammary gland. Endocrine 4, 115-122.
12. Evans, G. L., Bryant, H. U., Magee, D. E., and Turner, R. T. (1996). Raloxifene inhibits bone turnover and prevents further cancellous bone loss in adult ovariectomized rats with established osteopenia. Endocrinology 137, 4139-4144.
13. Glickman, B. W. (1996). Mutat. Res. Forum 1(4), 4.
14. Hill, A. B. (1965). The environment and disease: Association or causation? Proc. R. Soc. Med. 58, 295-300.
15. Katzenellenbogen, J. A. (1995). Commentary: The structural pervasiveness of estrogenic activity. Environ. Health Perspect. 103(Suppl. 7), 99-101.
16. Kavlock, R. J., Daston, G. P., DeRosa, C., Fenner-Crisp, P., Gray, L. E., Kaattari, S., Lucier, G., Luster, M., Mac, M. J., Maczka, C., Miller, R., Moore, J., Rolland, R., Scott, G., Sheehan, D. M., Sinks, T., and Tilson, H. A. (1996). Research needs for the risk assessment of health and environmental effects of endocrine disrupters: A report of the U.S. EPA-sponsored workshop. Environ. Health Perspect. 104(Suppl. 4), 715-740.
17. Lee, P. C., and Lee, W. (1996). In vivo estrogenic action of nonyl phenol in immature female rats. Bull. Environ. Contam. Toxicol. 57, 341-348.
18. Li, M. H., and Hansen, L. G. (1996). Enzyme induction and acute endocrine effects in prepubertal female rats receiving environmental PCB/PCDF/PCDD mixtures. Environ. Health Perspect. 104, 712-722.
19. Mellanen, P., Petanen, T., Lehtimaki, J., Makela, S., Bylund, G., Holmbom, B., Mannila, E., Oikari, A., and Santti, R. (1996). Wood-derived estrogens: Studies in vitro with breast cancer cell lines and in vivo in trout. Toxicol. Appl. Pharmacol. 136, 381-388.
20. O'Connor, J. C., Cook, J. C., Craven, S. C., Van Pelt, C. S., and Obourn, J. D. (1996). An in vivo battery for identifying endocrine modulators that are estrogenic or dopamine regulators. Fundam. Appl. Toxicol. 33, 182-195.
21. Odum, J., Lefevre, P. A., Tittensor, S., Paton, D., Harris, C. A., Beresford, N. A., Sumpter, J. P., and Ashby, J. (1997). The rodent uterotrophic assay: Critical protocol features, studies with nonylphe-nols, and comparison with a yeast estrogenicity assay. Reg. Toxicol. Pharmacol. 25, 176-188.
22. Ramamoorthy, K, Wang, F., Chen, I. C., Safe, S., Norris, J. D., McDonnell, D. P., Gaido, K. W., Bocchinfuso, W. P., and Korach, K. S. (1997). Potency of combined estrogenic pesticides. Science 275, 405.
23. Reel, J. R., Lamb, J. C., and Neal, B. H. (1996). Survey and assessment of mammalian estrogen biological assays for hazard characterization. Fundam. Appl. Toxicol. 34, 288-305.
24. Ren, L., Medahl, A., and Lech, J. J. (1996). Dimethyl formamide (DMFA) and ethylene glycol (EG) are estrogenic in rainbow trout. Chem. Biol. Interact. 102, 63-67.
25. Sharpe, R. M. (1993). Declining sperm counts in men - Is there an environmental cause? J. Endocrinol. 136, 357-360.
26. Sharpe, R. M., Fisher, J. S., Millar, M. M., Jobling, S., and Sumpter, J. P. (1995). Gestational and lactational exposure of rats to xenoestrogens results in reduced testicular size and sperm production. Environ. Health Perspect. 103, 1136-1143.
27. Shelby, M. D., Newbold, R. R., Tully, D. B., Chae, K., and Davis, V. L. (1996). Assessing environmental chemicals for estrogenicity using a combination of in vitro and in vivo assays. Environ. Health Perspect. 104, 1296-1300.
28. Tennant, R. W., Margolin, B. H., Shelby, M. D., Zeiger, E., Haseman, J. K., Spalding, J., Caspary, W., Resnick, M., Stasiewicz, S., Anderson, B., and Minor, R. (1987). Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science 236, 933-941.
29. Wakeling, A. E., and Valcaccia, B. (1983). Antiestrogenic and antitumour activities of a series of non-steroidal antiestrogens. J. Endocrinol. 99, 445-464.
30. Wakeling, A. E., Dukes, M., and Bowler, J. (1991). A potent pure antiestrogen with clinical potential. Cancer Res. 51, 3867-3873.
31. Waller, C. L., Oprea, T. I., Chae, K., Park, H-K., Korach, K S., Laws, S. C., Weise, T. E., Kelce, W. R., and Gray, L. E. (1996). Ligand-based identification of environmental estrogens. Chem. Res. Toxicol. 9, 1240-1248.
32. Yang, N. N., Venugopalan, M., Hardikar, S., and Glasebrook, A. (1996). Identification of an estrogen response element activated by metabolites of 17β-estradiol and raloxifene. Science 273, 1222-1225.